Cartesian Therapeutics RNAC
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.21 | 48.68 | -3.57 | -21,939 | -93 | |
| 2025Q3 | 10.22 | 58.68 | -1.38 | -21,066 | -36 | |
| 2025Q2 | 10.39 | -137.30 | 0.50 | -21,811 | 16 | |
| 2025Q1 | 13.18 | 123.60 | -0.68 | -21,889 | -18 | |
| 2024Q4 | 17.91 | -10.03 | -19,152 | -10 | ||
| 2024Q3 | 16.12 | 72.68 | -0.73 | -17,575 | -24 | |
| 2024Q2 | 27.01 | 99.43 | 6.62 | 13,757 | 14 | |
| 2024Q1 | 19.50 | 23.49 | -10.50 | -13,348 | -57 | |
| 2023Q4 | 20.68 | 18.47 | -41.56 | -36,332 | -178 | |
| 2023Q3 | 31.80 | 169.04 | -1.74 | -13,065 | -9 | |
| 2023Q2 | 33.60 | 175.25 | -2.22 | -18,638 | -11 | |
| 2023Q1 | 41.70 | 88.14 | 6.01 | -4.24 | -18,381 | -22 |
| 2022Q4 | 33.90 | -132.50 | 4.14 | -1.50 | -8,496 | 6 |
| 2022Q3 | 49.20 | 21.57 | 7.89 | -0.60 | -1,599 | -8 |